Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BALCHEM CORPBCPC · Entity 3839 | Director | February 11, 2026 | February 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BALCHEM CORP
Report date February 11, 2026 · Filed February 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,390 |
Reported balance
After 2026-02-11 transaction · row 1
1 source rowRow 1 · 2026-02-11 · Grant · Acquired 870 · Balance 2,390 F1: Ownership of restricted stock vests in Reporting Person 1 year following the grant date, subject to restrictions of transfer in accordance with the provisions of the Restricted Stock Grant Agreement between the Issuer and the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Ownership of restricted stock vests in Reporting Person 1 year following the grant date, subject to restrictions of transfer in accordance with the provisions of the Restricted Stock Grant Agreement between the Issuer and the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 11, 2026 Filed Feb 13, 2026 21:15 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 870 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-26-005434 · form4.xml · nonDerivative · entry 1 Rigaud Olivier · CIK 0001988789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,390 F1 · shares: Ownership of restricted stock vests in Reporting Person 1 year following the grant date, subject to restrictions of transfer in accordance with the provisions of the Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 21:15 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 980 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-25-004798 · form4.xml · nonDerivative · entry 1 Rigaud Olivier · CIK 0001988789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,520 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restriction of transfer in accordance with the provisions of the Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
| February 12, 2025 Filed Apr 11, 2025 21:04 UTC Amendment | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 980 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-25-013525 · form4.xml · nonDerivative · entry 1 Rigaud Olivier · CIK 0001988789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,520 F1 · shares: Ownership of restricted stock vests in Reporting Person 1 year following the grant date, subject to restriction of transfer in accordance with the provisions of the Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
| February 08, 2024 Filed Feb 13, 2024 00:08 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 1,730 | $0.00 Strike: $143.43 | $0.00 |
DisclosureSEC source: 0001140361-24-007152 · form4.xml · derivative · entry 2 Rigaud Olivier · CIK 0001988789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,730 Underlying: Common Stock · 1,730 shares Expires 2034-02-08 F2 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2; and 40% Year 3 Read SEC document |
| February 08, 2024 Filed Feb 13, 2024 00:08 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 540 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-007152 · form4.xml · nonDerivative · entry 1 Rigaud Olivier · CIK 0001988789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 540 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.